Lorven Biologics

Lorven Biologics is a biotechnology company based in Rockville, Maryland, dedicated to developing innovative vaccines and therapeutic biologics for infectious diseases and oncology. The company utilizes a proprietary "Plug and Play" platform for the rapid development of recombinant protein-based vaccines and monoclonal antibodies. Their current pipeline includes pre-clinical programs targeting high-priority viral pathogens such as Zika, Chikungunya, and seasonal influenza. Lorven Biologics focuses on creating scalable and cost-effective manufacturing processes to ensure global accessibility to their products. The company has received support from regional accelerators and state-level funding programs to advance its research and development initiatives.